.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Daiichi Sankyo
Johnson and Johnson
Accenture
Cerilliant
Covington
Baxter
Medtronic
Mallinckrodt

Generated: December 13, 2017

DrugPatentWatch Database Preview

TESTODERM Drug Profile

« Back to Dashboard

When do Testoderm patents expire, and when can generic versions of Testoderm launch?

Testoderm is a drug marketed by Alza and is included in two NDAs. There are two patents protecting this drug.

This drug has two patent family members in two countries.

The generic ingredient in TESTODERM is testosterone. There are sixty-two drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Drug patent expirations by year for TESTODERM

Medical Subject Heading (MeSH) Categories for TESTODERM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
AlzaTESTODERMtestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL019762-001Oct 12, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AlzaTESTODERMtestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL019762-002Oct 12, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AlzaTESTODERM TTStestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL020791-001Dec 18, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TESTODERM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AlzaTESTODERMtestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL019762-002Oct 12, 1993► Subscribe► Subscribe
AlzaTESTODERMtestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL019762-001Oct 12, 1993► Subscribe► Subscribe
AlzaTESTODERMtestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL019762-002Oct 12, 1993► Subscribe► Subscribe
AlzaTESTODERMtestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL019762-002Oct 12, 1993► Subscribe► Subscribe
AlzaTESTODERMtestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL019762-001Oct 12, 1993► Subscribe► Subscribe
AlzaTESTODERMtestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL019762-002Oct 12, 1993► Subscribe► Subscribe
AlzaTESTODERMtestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL019762-001Oct 12, 1993► Subscribe► Subscribe
AlzaTESTODERMtestosteroneFILM, EXTENDED RELEASE;TRANSDERMAL019762-001Oct 12, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TESTODERM

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)9706789► Subscribe
Australia6853596► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Mallinckrodt
Express Scripts
Johnson and Johnson
Fuji
Boehringer Ingelheim
McKinsey
Cerilliant
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot